179 related articles for article (PubMed ID: 16180338)
1. The release of soluble VAP-1/SSAO by 3T3-L1 adipocytes is stimulated by isoproterenol and low concentrations of TNFalpha.
García-Vicente S; Abella A; Viguerie N; Ros-Baró A; Camps M; Testar X; Palacín M; Zorzano A; Marti L
J Physiol Biochem; 2005 Jun; 61(2):395-401. PubMed ID: 16180338
[TBL] [Abstract][Full Text] [Related]
2. Adipocytes release a soluble form of VAP-1/SSAO by a metalloprotease-dependent process and in a regulated manner.
Abella A; García-Vicente S; Viguerie N; Ros-Baró A; Camps M; Palacín M; Zorzano A; Marti L
Diabetologia; 2004 Mar; 47(3):429-438. PubMed ID: 14968297
[TBL] [Abstract][Full Text] [Related]
3. Regulation of semicarbazide-sensitive amine oxidase expression by tumor necrosis factor-alpha in adipocytes: functional consequences on glucose transport.
Mercier N; Moldes M; El Hadri K; Fève B
J Pharmacol Exp Ther; 2003 Mar; 304(3):1197-208. PubMed ID: 12604697
[TBL] [Abstract][Full Text] [Related]
4. Origins of serum semicarbazide-sensitive amine oxidase.
Stolen CM; Yegutkin GG; Kurkijärvi R; Bono P; Alitalo K; Jalkanen S
Circ Res; 2004 Jul; 95(1):50-7. PubMed ID: 15178639
[TBL] [Abstract][Full Text] [Related]
5. Curcumin attenuates lipolysis stimulated by tumor necrosis factor-α or isoproterenol in 3T3-L1 adipocytes.
Xie XY; Kong PR; Wu JF; Li Y; Li YX
Phytomedicine; 2012 Dec; 20(1):3-8. PubMed ID: 23083815
[TBL] [Abstract][Full Text] [Related]
6. Glitazones inhibit human monoamine oxidase but their anti-inflammatory actions are not mediated by VAP-1/semicarbazide-sensitive amine oxidase inhibition.
Carpéné C; Bizou M; Tréguer K; Hasnaoui M; Grès S
J Physiol Biochem; 2015 Sep; 71(3):487-96. PubMed ID: 25572340
[TBL] [Abstract][Full Text] [Related]
7. SSAO/VAP-1 protein expression during mouse embryonic development.
Valente T; Solé M; Unzeta M
Dev Dyn; 2008 Sep; 237(9):2585-93. PubMed ID: 18729210
[TBL] [Abstract][Full Text] [Related]
8. Adipogenesis-related increase of semicarbazide-sensitive amine oxidase and monoamine oxidase in human adipocytes.
Bour S; Daviaud D; Gres S; Lefort C; Prévot D; Zorzano A; Wabitsch M; Saulnier-Blache JS; Valet P; Carpéné C
Biochimie; 2007 Aug; 89(8):916-25. PubMed ID: 17400359
[TBL] [Abstract][Full Text] [Related]
9. Semicarbazide-sensitive amine oxidase activation promotes adipose conversion of 3T3-L1 cells.
Mercier N; Moldes M; El Hadri K; Fève B
Biochem J; 2001 Sep; 358(Pt 2):335-42. PubMed ID: 11513731
[TBL] [Abstract][Full Text] [Related]
10. The production of coagulation factor VII by adipocytes is enhanced by tumor necrosis factor-α or isoproterenol.
Takahashi N; Yoshizaki T; Hiranaka N; Kumano O; Suzuki T; Akanuma M; Yui T; Kanazawa K; Yoshida M; Naito S; Fujiya M; Kohgo Y; Ieko M
Int J Obes (Lond); 2015 May; 39(5):747-54. PubMed ID: 25504041
[TBL] [Abstract][Full Text] [Related]
11. Molecular cloning of a major mRNA species in murine 3T3 adipocyte lineage. differentiation-dependent expression, regulation, and identification as semicarbazide-sensitive amine oxidase.
Moldes M; Fève B; Pairault J
J Biol Chem; 1999 Apr; 274(14):9515-23. PubMed ID: 10092636
[TBL] [Abstract][Full Text] [Related]
12. Blood-brain barrier dysfunction underlying Alzheimer's disease is induced by an SSAO/VAP-1-dependent cerebrovascular activation with enhanced Aβ deposition.
Solé M; Esteban-Lopez M; Taltavull B; Fábregas C; Fadó R; Casals N; Rodríguez-Álvarez J; Miñano-Molina AJ; Unzeta M
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2189-2202. PubMed ID: 31047972
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin blocks soluble SSAO/VAP-1 release in experimental models of cerebral ischemia: Possible benefits for stroke-induced inflammation control.
Sun P; Hernandez-Guillamón M; Campos-Martorell M; Simats A; Montaner J; Unzeta M; Solé M
Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):542-553. PubMed ID: 29175057
[TBL] [Abstract][Full Text] [Related]
14. Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 activity exerts an antidiabetic action in Goto-Kakizaki rats.
Abella A; Marti L; Camps M; Claret M; Fernández-Alvarez J; Gomis R; Gumà A; Viguerie N; Carpéné C; Palacín M; Testar X; Zorzano A
Diabetes; 2003 Apr; 52(4):1004-13. PubMed ID: 12663473
[TBL] [Abstract][Full Text] [Related]
15. Substrates of semicarbazide-sensitive amine oxidase co-operate with vanadate to stimulate tyrosine phosphorylation of insulin-receptor-substrate proteins, phosphoinositide 3-kinase activity and GLUT4 translocation in adipose cells.
Enrique-Tarancón G; Castan I; Morin N; Marti L; Abella A; Camps M; Casamitjana R; Palacín M; Testar X; Degerman E; Carpéné C; Zorzano A
Biochem J; 2000 Aug; 350 Pt 1(Pt 1):171-80. PubMed ID: 10926841
[TBL] [Abstract][Full Text] [Related]
16. New efficient substrates for semicarbazide-sensitive amine oxidase/VAP-1 enzyme: analysis by SARs and computational docking.
Yraola F; García-Vicente S; Fernandez-Recio J; Albericio F; Zorzano A; Marti L; Royo M
J Med Chem; 2006 Oct; 49(21):6197-208. PubMed ID: 17034126
[TBL] [Abstract][Full Text] [Related]
17. Obesity of mice lacking VAP-1/SSAO by Aoc3 gene deletion is reproduced in mice expressing a mutated vascular adhesion protein-1 (VAP-1) devoid of amine oxidase activity.
Jargaud V; Bour S; Tercé F; Collet X; Valet P; Bouloumié A; Guillemot JC; Mauriège P; Jalkanen S; Stolen C; Salmi M; Smith DJ; Carpéné C
J Physiol Biochem; 2021 Feb; 77(1):141-154. PubMed ID: 32712883
[TBL] [Abstract][Full Text] [Related]
18. Vascular cell lines expressing SSAO/VAP-1: a new experimental tool to study its involvement in vascular diseases.
Solé M; Unzeta M
Biol Cell; 2011 Nov; 103(11):543-57. PubMed ID: 21819380
[TBL] [Abstract][Full Text] [Related]
19. Interleukin (IL)-6 mRNA expression is stimulated by insulin, isoproterenol, tumour necrosis factor alpha, growth hormone, and IL-6 in 3T3-L1 adipocytes.
Fasshauer M; Klein J; Lossner U; Paschke R
Horm Metab Res; 2003 Mar; 35(3):147-52. PubMed ID: 12734774
[TBL] [Abstract][Full Text] [Related]
20. Semicarbazide-sensitive amine oxidase substrates stimulate glucose transport and inhibit lipolysis in human adipocytes.
Morin N; Lizcano JM; Fontana E; Marti L; Smih F; Rouet P; Prévot D; Zorzano A; Unzeta M; Carpéné C
J Pharmacol Exp Ther; 2001 May; 297(2):563-72. PubMed ID: 11303044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]